Hexamethylmelamine (altretamine): early National Cancer Institute trials.
Young
R C
RC
Fox Chase Cancer Center, Philadelphia, PA 19111.
D006585:Altretamine / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D009316:National Institutes of Health (U.S.); D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014481:United States
D003520:Cyclophosphamide; D006585:Altretamine; D005472:Fluorouracil; D008727:Methotrexate